HBM Holdings Limited (HKG:2142)
Hong Kong
· Delayed Price · Currency is HKD 14.20
+0.46 (3.35%)
At close: Dec 5, 2025
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 12.35 billion as of December 5, 2025. Its market cap has increased by 1,327.07% in one year.
Market Cap
12.35B
Enterprise Value
10.34B
Revenue
908.35M
Ranking
n/a
PE Ratio
19.64
Stock Price
14.20
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 12.35B, an increase of 45.89%. That is a compound annual growth rate of 7.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.35B | 806.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | 8.11B | -4.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| JD Health International | 192.73B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 134.32B |
| Sino Biopharmaceutical | 122.28B |
| Akeso | 114.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |